Essentially Group PLC Notice of General Meeting

RNS Number : 5248G

Essentially Group PLC

12 March 2024

 

ESSENTIALLY GROUP PLC

 

("Essentially" or "the Company'')

 

Notice of General Meeting

 

Essentially Group PLC (AQSE: ESSN) is pleased to announce that the notice of General Meeting and Form of Proxy were posted to shareholders yesterday. Both the Notice of General Meeting and the Form of Proxy are available on the Company's website https://essentiallyplc.com/.

 

The General Meeting will be held at the offices of Essentially Juices Manufacturing LLC, Unit S06 & S07, Al Quoz Industrial Area 2, Al Khail Gate, Dubai, United Arab Emirates, and via digital conference call details of which will be circulated in advance of the General Meeting, on Wednesday 3rd April 2024 at 09:00am (GMT).

 

 

- end -

 

For further information, please contact:

 

Essentially Group Plc
Raja W Abuljebain, CEO	Tel: [phone]
	https://essentiallyplc.com
AQSE Exchange Corporate Adviser
Alfred Henry Corporate Finance Ltd
Nick Michaels/Maya Klein Wassink	Tel: [phone]
	www.alfredhenry.com
Broker
Clear Capital Markets Ltd
Andrew Blaylock	Tel: [phone]
	https://clearcapitalmarkets.co.uk

 

About Essentially Group PLC

 

Essentially's mission and strategy is the acquisition, holding and development of companies active in the health food and beverages market.  Essentially's wholly owned operating subsidiary in the United Arab Emirates ("UAE"), Essentially Juices Manufacturing LLC ("EJM"), offers premium quality wellness shots, functional juices, lemonades, nut milks, single origin fruit juices and healthy protein snacks. EJM has a manufacturing facility in Dubai where the beverages are produced and is active in the UAE and Kingdom of Saudi Arabia fruit and vegetable juice market.

 

For more information on the Company please visit  https://essentiallyplc.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NEXFLFFIVIIFLIS